Search

Your search keyword '"Dacić, Sanja"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Dacić, Sanja" Remove constraint Author: "Dacić, Sanja"
151 results on '"Dacić, Sanja"'

Search Results

2. Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study

3. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment

5. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer

6. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

7. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

9. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

10. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

12. Solid papillary mesothelial tumor

15. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis

16. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

17. Prognostic Biomarkers in Lung Cancer

18. Translocation Testing of Lung Cancer Biomarkers

19. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

20. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

21. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

22. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

23. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

27. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach

28. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

30. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

31. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung

32. THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer

33. Scientific Advances in Thoracic Oncology 2016

35. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

37. Molecular Targeted Therapy of Lung Cancer

43. Molecular Prognostic Markers of Lung Cancer

45. Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study

50. Tiazofurin modulates lipopolysaccharide-activated microglia in vitro

Catalog

Books, media, physical & digital resources